169 related articles for article (PubMed ID: 37658139)
1. MRI-based automated machine learning model for preoperative identification of variant histology in muscle-invasive bladder carcinoma.
Huang J; Chen G; Liu H; Jiang W; Mai S; Zhang L; Zeng H; Wu S; Chen CY; Wu Z
Eur Radiol; 2024 Mar; 34(3):1804-1815. PubMed ID: 37658139
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder.
Minato A; Noguchi H; Tomisaki I; Fukuda A; Kubo T; Nakayama T; Fujimoto N
Cancer Control; 2018; 25(1):1073274818800269. PubMed ID: 30213195
[TBL] [Abstract][Full Text] [Related]
3. Bladder Urothelial Carcinoma: Machine Learning-based Computed Tomography Radiomics for Prediction of Histological Variant.
Evrimler S; Ali Gedik M; Ahmet Serel T; Ertunc O; Alperen Ozturk S; Soyupek S
Acad Radiol; 2022 Nov; 29(11):1682-1689. PubMed ID: 35351362
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic and Survival After Cystectomy Outcomes in Squamous Cell Carcinoma of the Bladder.
Agrawal P; Rostom M; Alam R; Florissi I; Biles M; Rodriguez K; Hahn NM; Johnson BA; Matoso A; Smith A; Bivalacqua TJ; Kates M; Hoffman-Censits J; Patel SH
Clin Genitourin Cancer; 2023 Dec; 21(6):631-638.e1. PubMed ID: 37336703
[TBL] [Abstract][Full Text] [Related]
5. A machine learning model based on MRI for the preoperative prediction of bladder cancer invasion depth.
Chen G; Fan X; Wang T; Zhang E; Shao J; Chen S; Zhang D; Zhang J; Guo T; Yuan Z; Tang H; Yu Y; Chen J; Wang X
Eur Radiol; 2023 Dec; 33(12):8821-8832. PubMed ID: 37470826
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
[TBL] [Abstract][Full Text] [Related]
7. Development of a noninvasive tool to preoperatively evaluate the muscular invasiveness of bladder cancer using a radiomics approach.
Zheng J; Kong J; Wu S; Li Y; Cai J; Yu H; Xie W; Qin H; Wu Z; Huang J; Lin T
Cancer; 2019 Dec; 125(24):4388-4398. PubMed ID: 31469418
[TBL] [Abstract][Full Text] [Related]
8. Surgical management of bladder urothelial carcinoma with squamous differentiation.
Raman JD; Jafri SM
Urol Oncol; 2015 Oct; 33(10):429-33. PubMed ID: 26206104
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Identification of Nonmuscle-Invasive and Muscle-Invasive Bladder Carcinomas: A Multiparametric MRI Radiomics Analysis.
Xu X; Zhang X; Tian Q; Wang H; Cui LB; Li S; Tang X; Li B; Dolz J; Ayed IB; Liang Z; Yuan J; Du P; Lu H; Liu Y
J Magn Reson Imaging; 2019 May; 49(5):1489-1498. PubMed ID: 30252978
[TBL] [Abstract][Full Text] [Related]
10. Pathological Downstaging and Survival Outcomes Associated with Neoadjuvant Chemotherapy for Variant Histology Muscle Invasive Bladder Cancer.
Chakiryan NH; Jiang DD; Gillis KA; Green E; Hajiran A; Hugar L; Zemp L; Zhang J; Jain R; Chahoud J; Poch M; Manley BJ; Li R; Sexton W; Gilbert SM
J Urol; 2021 Oct; 206(4):924-932. PubMed ID: 34032503
[TBL] [Abstract][Full Text] [Related]
11. Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies.
Necchi A; Raggi D; Gallina A; Madison R; Colecchia M; Lucianò R; Montironi R; Giannatempo P; Farè E; Pederzoli F; Bandini M; Bianchi M; Colombo R; Gandaglia G; Fossati N; Marandino L; Capitanio U; Dehò F; Ali SM; Chung JH; Ross JS; Salonia A; Briganti A; Montorsi F
Eur Urol; 2020 Apr; 77(4):439-446. PubMed ID: 31708296
[TBL] [Abstract][Full Text] [Related]
12. Elaboration of a multisequence MRI-based radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer: a double-center study.
Wang H; Xu X; Zhang X; Liu Y; Ouyang L; Du P; Li S; Tian Q; Ling J; Guo Y; Lu H
Eur Radiol; 2020 Sep; 30(9):4816-4827. PubMed ID: 32318846
[TBL] [Abstract][Full Text] [Related]
13. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M
Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387
[TBL] [Abstract][Full Text] [Related]
14. Amide Proton Transfer-Weighted MRI and Diffusion-Weighted Imaging in Bladder Cancer: A Complementary Tool to the VI-RADS.
Kong L; Wen Z; Cai Q; Lin Y; Chen Y; Cao W; Li M; Qian L; Chen J; Guo Y; Wang H
Acad Radiol; 2024 Feb; 31(2):564-571. PubMed ID: 37821347
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a fractional-order calculus diffusion model and bi-parametric VI-RADS for staging and grading bladder urothelial carcinoma.
Feng C; Wang Y; Dan G; Zhong Z; Karaman MM; Li Z; Hu D; Zhou XJ
Eur Radiol; 2022 Feb; 32(2):890-900. PubMed ID: 34342693
[TBL] [Abstract][Full Text] [Related]
16. Combining DWI radiomics features with transurethral resection promotes the differentiation between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer.
Xu S; Yao Q; Liu G; Jin D; Chen H; Xu J; Li Z; Wu G
Eur Radiol; 2020 Mar; 30(3):1804-1812. PubMed ID: 31773297
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy.
Li Q; Assel M; Benfante NE; Pietzak EJ; Herr HW; Donat M; Cha EK; Donahue TF; Bochner BH; Dalbagni G
Eur Urol Focus; 2019 Jan; 5(1):104-108. PubMed ID: 28753857
[TBL] [Abstract][Full Text] [Related]
18. Plasmacytoid variant urothelial bladder cancer: is it time to update the treatment paradigm?
Kaimakliotis HZ; Monn MF; Cary KC; Pedrosa JA; Rice K; Masterson TA; Gardner TA; Hahn NM; Foster RS; Bihrle R; Cheng L; Koch MO
Urol Oncol; 2014 Aug; 32(6):833-8. PubMed ID: 24954925
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of pretreatment inflammatory markers in variant histologies of the bladder: is inflammation linked to survival after radical cystectomy?
Rodler S; Buchner A; Ledderose ST; Eismann L; Volz Y; Pfitzinger P; Kretschmer A; Schulz GB; Karl A; Schlenker B; Stief CG; Jokisch F
World J Urol; 2021 Jul; 39(7):2537-2543. PubMed ID: 33084922
[TBL] [Abstract][Full Text] [Related]
20. Determining the clinicopathological significance of the VI-RADS ≧4 group: a retrospective study.
Ikuma S; Akatsuka J; Takeda H; Endo Y; Kiriyama T; Hamasaki T; Kimura G; Kondo Y
BMC Urol; 2024 Mar; 24(1):63. PubMed ID: 38509503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
